209 related articles for article (PubMed ID: 33860801)
1. Regulation of MST complexes and activity via SARAH domain modifications.
Karchugina S; Benton D; Chernoff J
Biochem Soc Trans; 2021 Apr; 49(2):675-683. PubMed ID: 33860801
[TBL] [Abstract][Full Text] [Related]
2. Salvador has an extended SARAH domain that mediates binding to Hippo kinase.
Cairns L; Tran T; Fowl BH; Patterson A; Kim YJ; Bothner B; Kavran JM
J Biol Chem; 2018 Apr; 293(15):5532-5543. PubMed ID: 29519817
[TBL] [Abstract][Full Text] [Related]
3. Structural insight into dimeric interaction of the SARAH domains from Mst1 and RASSF family proteins in the apoptosis pathway.
Hwang E; Ryu KS; Pääkkönen K; Güntert P; Cheong HK; Lim DS; Lee JO; Jeon YH; Cheong C
Proc Natl Acad Sci U S A; 2007 May; 104(22):9236-41. PubMed ID: 17517604
[TBL] [Abstract][Full Text] [Related]
4. Structural basis of the heterodimerization of the MST and RASSF SARAH domains in the Hippo signalling pathway.
Hwang E; Cheong HK; Ul Mushtaq A; Kim HY; Yeo KJ; Kim E; Lee WC; Hwang KY; Cheong C; Jeon YH
Acta Crystallogr D Biol Crystallogr; 2014 Jul; 70(Pt 7):1944-53. PubMed ID: 25004971
[TBL] [Abstract][Full Text] [Related]
5. Biophysical characterization of SARAH domain-mediated multimerization of Hippo pathway complexes in
Cairns L; Patterson A; Weingartner KA; Koehler TJ; DeAngelis DR; Tripp KW; Bothner B; Kavran JM
J Biol Chem; 2020 May; 295(18):6202-6213. PubMed ID: 32213597
[TBL] [Abstract][Full Text] [Related]
6. Structural and thermodynamic characterization of Nore1-SARAH: a small, helical module important in signal transduction networks.
Makbul C; Constantinescu Aruxandei D; Hofmann E; Schwarz D; Wolf E; Herrmann C
Biochemistry; 2013 Feb; 52(6):1045-54. PubMed ID: 23331050
[TBL] [Abstract][Full Text] [Related]
7. Angiomotins stimulate LATS kinase autophosphorylation and act as scaffolds that promote Hippo signaling.
Mana-Capelli S; McCollum D
J Biol Chem; 2018 Nov; 293(47):18230-18241. PubMed ID: 30266805
[TBL] [Abstract][Full Text] [Related]
8. Low pH-driven folding of WW45-SARAH domain leads to stabilization of the WW45-Mst2 complex.
Song J; Hong HR; Yamashita E; Park IY; Lee SJ
J Biochem; 2015 Sep; 158(3):181-8. PubMed ID: 25814670
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of miR-181c contributes to chemoresistance in pancreatic cancer by inactivating the Hippo signaling pathway.
Chen M; Wang M; Xu S; Guo X; Jiang J
Oncotarget; 2015 Dec; 6(42):44466-79. PubMed ID: 26561204
[TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of interactions of RASSF1-10.
Chan JJ; Flatters D; Rodrigues-Lima F; Yan J; Thalassinos K; Katan M
Adv Biol Regul; 2013 May; 53(2):190-201. PubMed ID: 23357313
[TBL] [Abstract][Full Text] [Related]
11. Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver.
Lu L; Li Y; Kim SM; Bossuyt W; Liu P; Qiu Q; Wang Y; Halder G; Finegold MJ; Lee JS; Johnson RL
Proc Natl Acad Sci U S A; 2010 Jan; 107(4):1437-42. PubMed ID: 20080689
[TBL] [Abstract][Full Text] [Related]
12. WWC proteins mediate LATS1/2 activation by Hippo kinases and imply a tumor suppression strategy.
Qi S; Zhu Y; Liu X; Li P; Wang Y; Zeng Y; Yu A; Wang Y; Sha Z; Zhong Z; Zhu R; Yuan H; Ye D; Huang S; Ling C; Xu Y; Zhou D; Zhang L; Yu FX
Mol Cell; 2022 May; 82(10):1850-1864.e7. PubMed ID: 35429439
[TBL] [Abstract][Full Text] [Related]
13. A WW Tandem-Mediated Dimerization Mode of SAV1 Essential for Hippo Signaling.
Lin Z; Xie R; Guan K; Zhang M
Cell Rep; 2020 Sep; 32(10):108118. PubMed ID: 32905778
[TBL] [Abstract][Full Text] [Related]
14. The cell adhesion molecule echinoid functions as a tumor suppressor and upstream regulator of the Hippo signaling pathway.
Yue T; Tian A; Jiang J
Dev Cell; 2012 Feb; 22(2):255-67. PubMed ID: 22280890
[TBL] [Abstract][Full Text] [Related]
15. Dimerization and cytoplasmic localization regulate Hippo kinase signaling activity in organ size control.
Jin Y; Dong L; Lu Y; Wu W; Hao Q; Zhou Z; Jiang J; Zhao Y; Zhang L
J Biol Chem; 2012 Feb; 287(8):5784-96. PubMed ID: 22215676
[TBL] [Abstract][Full Text] [Related]
16. KIBRA connects Hippo signaling and cancer.
Swaroop B SS; Kanumuri R; Ezhil I; Naidu Sampangi JK; Kremerskothen J; Rayala SK; Venkatraman G
Exp Cell Res; 2021 Jun; 403(2):112613. PubMed ID: 33901448
[TBL] [Abstract][Full Text] [Related]
17. MAP4K family kinases act in parallel to MST1/2 to activate LATS1/2 in the Hippo pathway.
Meng Z; Moroishi T; Mottier-Pavie V; Plouffe SW; Hansen CG; Hong AW; Park HW; Mo JS; Lu W; Lu S; Flores F; Yu FX; Halder G; Guan KL
Nat Commun; 2015 Oct; 6():8357. PubMed ID: 26437443
[TBL] [Abstract][Full Text] [Related]
18. H-ras Inhibits the Hippo Pathway by Promoting Mst1/Mst2 Heterodimerization.
Rawat SJ; Araiza-Olivera D; Arias-Romero LE; Villamar-Cruz O; Prudnikova TY; Roder H; Chernoff J
Curr Biol; 2016 Jun; 26(12):1556-1563. PubMed ID: 27238285
[TBL] [Abstract][Full Text] [Related]
19. STK25 suppresses Hippo signaling by regulating SAV1-STRIPAK antagonism.
Bae SJ; Ni L; Luo X
Elife; 2020 Apr; 9():. PubMed ID: 32292165
[TBL] [Abstract][Full Text] [Related]
20. Inhibiting Hippo pathway kinases releases WWC1 to promote AMPAR-dependent synaptic plasticity and long-term memory in mice.
Stepan J; Heinz DE; Dethloff F; Wiechmann S; Martinelli S; Hafner K; Ebert T; Junglas E; Häusl AS; Pöhlmann ML; Jakovcevski M; Pape JC; Zannas AS; Bajaj T; Hermann A; Ma X; Pavenstädt H; Schmidt MV; Philipsen A; Turck CW; Deussing JM; Rammes G; Robinson AC; Payton A; Wehr MC; Stein V; Murgatroyd C; Kremerskothen J; Kuster B; Wotjak CT; Gassen NC
Sci Signal; 2024 Apr; 17(834):eadj6603. PubMed ID: 38687825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
